MiMedx (NSDQ:MDXG) today claimed an early win in its proxy war with the CEO it fired for cause last year, saying that shareholders elected its slate of directors to the board, including new chief executive Timothy Wright. Marietta, Ga.-based MiMedx makes regenerative and therapeutic biologics using human placental tissue allografts. The ouster last year of then-CEO […]
MiMedx continues fight against proxy challenge from ex-CEO Petit
MiMedx (NSDQ:MDXG) today urged its shareholders to vote for its nominees as it faces a proxy challenge from former CEO Parker Petit, who was ousted last July “for cause.” The Marietta, Ga.-based company is under a court order to hold its annual shareholder meeting on June 17, but said in April that it plans to appeal the ruling. […]
MiMedx inks board reorganization plan with major shareholder
MiMedx (NSDQ:MDXG) said today that its board of directors adopted a new “comprehensive plan” to refresh its board composition in cooperation with major shareholder Prescience Point Capital Management. CEO Timothy Wright, who moved into the corner office earlier this month, will be added to the board, the Marietta, Ga.-based company said. In addition, class II and […]
MiMedx: Ex-managers cooked the books, went after whistleblowers
The former management team at MiMedx (NSDQ:MDXG), led by ex-CEO Parker Petit, allegedly enacted a scheme to cook the books at the regenerative medicine company, retaliated against anyone who questioned their sketchy accounting practices and secretly filmed their offices, according to a probe the company launched after the scheme blew up last year. In February 2018, […]
MiMedx names Wright as CEO | Personnel Moves – May 9, 2019
MiMedx (NSDQ:MDXG) said today that it it named Timothy Wright as its new chief exec, effective May 13. Wright will replace David Coles, who has served as the interim CEO since last July, the Marietta, Ga.-based company said. MiMedx said that Wright has more than 30 years of experience in pharma, medtech and biotech. Prior to […]
MiMedx fights court order to hold annual shareholder meeting in June
MiMedx (NSDQ:MDXG) said yesterday that it’s under a court order to hold its 2018 annual shareholder meeting June 17. The Marietta, Ga.-based company said that it plans to appeal the ruling, but is still planning to hold the meeting on that date. “In all events, the company desires to hold the 2018 annual meeting at a […]
Ex-MiMedx CEO Petit mounts proxy war
MiMedx (NSDQ:MDXG) is facing a proxy battle being led by former CEO Parker Petit, who was ousted last July “for cause”, according to a recently posted SEC filing. The ex chief-exec nominated himself alongside former Pulte Home Corp tax director David Furstenburger and George & Lorenson partner Shawn George as candidates for the company’s board of […]
MiMedx escapes Osiris trade theft suit
MiMedx (NSDQ:MDXG) enjoyed a rare spot of good news when a federal judge in Maryland this week dismissed a trade theft and breach-of-contract lawsuit brought by Osiris Therapeutics over MiMedx’s Stability Biologics acquisition. Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after […]
MiMedx accounting firm quits
The troubles at MiMedx (NSDQ:MDXG) continued last week with the resignation of the accounting firm tapped to audit its books in the wake of a financial scandal. Marietta, Ga.-based MiMedx last July ousted ex-CEO Parker Petit and president & COO William Taylor amid a board-directed independent investigation that had already prompted the departure of CFO Michael Senken and treasurer John […]
MiMedx to lay off 24% of workforce in restructuring effort
MiMedx (NSDQ:MDXG) said yesterday that it plans to eliminate 24% of its total workforce as part of a larger overall plan to reduce cost and improve efficiency. The Marietta, Ga.-based company said that it plans to eliminate 240 full-time employees, with approximately half of those cuts coming from the salesforce. The plan also includes reducing costs […]
Report: MiMedx held lower-cost grafts from federal hospitals
MiMedx (NSDQ:MDXG), already embroiled in an internal accounting snafu and several federal probes, reportedly held from government hospitals some of the lower-cost products it made available to private hospitals. In limiting its regenerative wound care offering to U.S. Veteran Affairs Dept. and other federal caregivers, Marietta, Ga.-based MiMedx ran up the tab on taxpayers, the Wall […]
- 1
- 2
- 3
- …
- 5
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube